We empirically investigate a type of technological boundary spanning-oriented search in which firms apply knowledge from one technical domain to innovate in another, a phenomenon we term knowledge bridging. In an analysis of a novel dataset of all the biotechnology firms founded to commercialize...

In the context of the emergence of new modular organizational forms, especially in high-tech sectors such as the biotechnology sector, this article proposes that while a firm observes benefits from direct alliances, it also benefits from indirect linkages. First, a theoretical framework...

The objective of the study was to empirically verify impacts of intellectual capital (IC) to the anticipated future sales of small- and medium-sized companies within the biotechnology industry. The study creates and develops tools for the valuation of companies by relating the existing...

We examine reverse mergers (RMs) in the biotechnology industry and find that, when compared to initial public offerings (IPOs), RMs are smaller, have significantly lower market valuations relative to size, and generally invest less. We also find that RMs exhibit positive abnormal returns on the...

Venture Capitalists (VCs) base their investment decision on reliable criteria to predict future performance of start-ups. However, many studies have ignored potential discrepancies in relative importance of various decision criteria that might occur when focusing on a special industry or a...

In contrast to the whirlwind pace and the efficiency with which the science and commercialization of modern biotechnology have developed in the past few decades, the creation of an adequate and comprehensive regulatory regime for agricultural biotechnology has proven to be a lengthy and arduous...

The conventional view of science-based businesses focuses on the inseparability of the roles of the inventor generating the underlying idea and the Schumpeterian entrepreneur who implements it in practice. We present an equilibrium model of science-based entrepreneurship where scientific ideas...

While some would like to present Jewish legends of the golem as a pro-biotechnology answer to the cautionary tale of Frankenstein's monster, examination of Shelley's Frankenstein and Rosenberg's The Golem and the Wondrous Deeds of the Maharal of Prague identifies some common issues with respect...

The biotech cluster in San Diego is dominated by small firms, with approximately 73% of the firms employing between 1 to 49 employees. Among the main important sources of financing for the biotech companies are venture capital and initial public offerings. In spite of the aggregate increase in...

This paper compares and contrasts how innovation – the successful introduction of new products, services, or techniques – is occurring in biotechnology seeds in China and India. We begin with an overview of the agricultural challenges faced by China and India and the substantial investments...